PCLI Welcomes New Members to Steering Committee

Six new members have been selected to join AACI’s Physician Clinical Leadership Initiative (PCLI) Steering Committee: 

  • Steven R. Alberts, MD, medical director, clinical research office, Mayo Clinic Cancer Center 
  • Julie Brahmer, MD, director, thoracic oncology program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
  • Lisa Carey, MD, FASCO, chief, division of hematology/oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  • Merry Jennifer Markham, MD, FACP, interim chief, division of hematology & oncology and associate director for medical affairs, University of Florida Health Cancer Center
  • Jessica Rhee, MD, MS, medical director, clinical trials office, University of Hawai'i Cancer Center, University of Hawai'i at Mānoa 
  • John Sweetenham, MD, FRCP, FACP, FASCO, associate director of clinical affairs, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

The new members’ terms began January 1.

The steering committee would like to thank the following outgoing members for their time and commitment in guiding the initiative and planning the annual PCLI meeting:

  • Craig Bunnell, MD, MPH, MBA, chief medical officer, Dana-Farber Cancer Institute, Harvard Medical School
  • Richard Goldberg, MD, FACP, FASCO, director, WVU Cancer Institute
  • Randall F. Holcombe, MD, MBA, director of the University of Hawai'i Cancer Center, University of Hawai'i at Mānoa
  • Dan Mulkerin, MD, medical director and associate professor, University of Wisconsin Carbone Cancer Center

Now entering its eighth year, PCLI pursues a variety of objectives, including developing better methods to disseminate information across cancer centers; identifying and addressing oncology care model barriers; and measuring quality. Last year PCLI presented webinars on telemedicine and hereditary cancer programs, and convened at the 2019 AACI/CCAF Annual Meeting. The annual meeting program focused on strategic initiatives supporting health research activities for sexual and gender minorities and the impact of financial toxicities on patient care.